PBT fell 54.8% and leverage rose to 4.9x EBITDA

The more pressing movement is in cash and leverage: operating cash flow dropped 76.6% to $4.5m, cash conversion (OCF/EBITDA) fell to 12.3% from 38.8%, and free cash flow before lease payments deteriorated to -$9.4m from -$5.9m despite capex being cut 44.5% to $13.9m. Gross borrowings rose 7.8% to $182.2m, lifting net debt/EBITDA to 4.9x from 3.3x.

Segment economics also deteriorated. Orchard operations swung to a $3.1m loss from a $3.7m profit, and Australian operations swung to a $0.5m loss from a $1.6m profit. Post-harvest, the dominant segment at 71% of revenue, held its margin at roughly 24.5% but revenue fell 15.4%, reflecting the industry-wide yield drop management flagged.

Net debt/EBITDA at 4.9x is a step change from 3.3x a year ago, driven jointly by lower trailing EBITDA and a $13.2m increase in gross borrowings. With seasonally dominant earnings already booked, headroom against covenants and refinancing assumptions will tighten as second-half losses are absorbed.

Cash quality fell sharply, masked by working-capital release. OCF fell 77% against EBITDA -26%. A $17.9m release of operating working capital (debtors -$14.6m, inventory -$3.3m) actually flattered the cash number; without it, OCF would have been negative. This matters because the receivable run-off is seasonal and unlikely to repeat, so second-half cash is likely to be worse than the first-half headline suggests.

Segment losses point to structural, not cyclical, pressure. Orchard operations and Australian operations both swung from profit to loss. Lower yields explain part of this, but two segments simultaneously crossing zero indicates fixed-cost deleverage that may persist while volumes remain depressed.

Seasonality context is therefore the most useful anchor, and it is unflattering: HY22 represented 71% of FY22 revenue, 107% of FY22 EBITDA, and 330% of FY22 NPAT, with H2 22 delivering -$3.3m EBITDA and -$15.0m NPAT. Applying that pattern, FY23 EBITDA could be materially lower than HY23's $36.4m and NPAT could be loss-making, which is what makes the 4.9x leverage reading important rather than incidental.

The release contains qualitative comments about international sales strength and grower investment in SunGold but nothing that quantifies a second-half recovery, so the gap between this print and a credible full-year shape remains open.

PBT growth of -54.8% is the cleaner operating read than NPAT growth of -51.2%, because the effective tax rate fell to 23.2% from 28.6% and softened the NPAT line by roughly 3.6 percentage points of growth.

On cash, free cash flow before leases worsened despite a 44.5% capex cut, and the $17.9m working-capital release did the heavy lifting in keeping OCF positive. That combination — capex deferral plus a non-repeating working-capital tailwind plus still-negative FCF — means the underlying cash burn is worse than the $4.5m OCF line implies. ROE halved to 3.8% from 7.8%, consistent with the operating deterioration rather than a one-off.

No dividend was declared (HY22: also nil), so capital allocation does not add further strain, but it also signals the board is not treating the result as transitory.

This briefing cannot assess covenant terms, forward-work pipeline, or 2024-crop yield expectations because none are disclosed in the release.